Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Neal

Showing results (231-240 of 484) with videos related to

Pageof 49
Sort By:
Plos Medicine|August 29, 2012
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysisJicheng Lv, Bruce Neal, Parya Ehteshami, et al.
Diabetes Care|October 6, 2011
Does glycemic control offer similar benefits among patients with diabetes in different regions of the world? Results from the ADVANCE trialMark Woodward, Anushka Patel, Sophia Zoungas, et al.
Cardiovascular Diabetology|September 23, 2022
Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failureSok Cin Tye, Niels Jongs, Steven G Coca, et al.
Nutrients|February 6, 2019
Sources of Dietary Salt in North and South India Estimated from 24 Hour Dietary RecallClaire Johnson, Joseph Alvin Santos, Emalie Sparks, et al.
Circulation|March 19, 2019
Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes MellitusGemma A Figtree, Karin Rådholm, Terrance D Barrett, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2014
Degree of blood pressure reduction and recurrent stroke: the PROGRESS trialHisatomi Arima, Craig Anderson, Teruo Omae, et al.
Kidney International|May 30, 2020
Mediators of the effects of canagliflozin on kidney protection in patients with type 2 diabetesJingWei Li, Bruce Neal, Vlado Perkovic, et al.
European Journal of Preventive Cardiology|June 1, 2013
Tobacco use, smoking quit rates, and socioeconomic patterning among men and women: a cross-sectional survey in rural Andhra Pradesh, IndiaDaniel J Corsi, S V Subramanian, Scott A Lear, et al.
Nutrients|December 24, 2015
Dietary Salt Intake and Discretionary Salt Use in Two General Population Samples in Australia: 2011 and 2014Caryl Nowson, Karen Lim, Carley Grimes, et al.
Journal of the American College of Cardiology|February 4, 2022
Stress Cardiac Biomarkers, Cardiovascular and Renal Outcomes, and Response to CanagliflozinMuthiah Vaduganathan, Naveed Sattar, Jialin Xu, et al.
Pageof 49

Showing results (231-240 of 484) with videos related to

Sort By:
Pageof 49
Plos Medicine|August 29, 2012
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysisJicheng Lv, Bruce Neal, Parya Ehteshami, et al.
Diabetes Care|October 6, 2011
Does glycemic control offer similar benefits among patients with diabetes in different regions of the world? Results from the ADVANCE trialMark Woodward, Anushka Patel, Sophia Zoungas, et al.
Cardiovascular Diabetology|September 23, 2022
Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failureSok Cin Tye, Niels Jongs, Steven G Coca, et al.
Nutrients|February 6, 2019
Sources of Dietary Salt in North and South India Estimated from 24 Hour Dietary RecallClaire Johnson, Joseph Alvin Santos, Emalie Sparks, et al.
Circulation|March 19, 2019
Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes MellitusGemma A Figtree, Karin Rådholm, Terrance D Barrett, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2014
Degree of blood pressure reduction and recurrent stroke: the PROGRESS trialHisatomi Arima, Craig Anderson, Teruo Omae, et al.
Kidney International|May 30, 2020
Mediators of the effects of canagliflozin on kidney protection in patients with type 2 diabetesJingWei Li, Bruce Neal, Vlado Perkovic, et al.
European Journal of Preventive Cardiology|June 1, 2013
Tobacco use, smoking quit rates, and socioeconomic patterning among men and women: a cross-sectional survey in rural Andhra Pradesh, IndiaDaniel J Corsi, S V Subramanian, Scott A Lear, et al.
Nutrients|December 24, 2015
Dietary Salt Intake and Discretionary Salt Use in Two General Population Samples in Australia: 2011 and 2014Caryl Nowson, Karen Lim, Carley Grimes, et al.
Journal of the American College of Cardiology|February 4, 2022
Stress Cardiac Biomarkers, Cardiovascular and Renal Outcomes, and Response to CanagliflozinMuthiah Vaduganathan, Naveed Sattar, Jialin Xu, et al.
Pageof 49